Researchers say most food chemicals are unknown to science — a hidden world of nutritional ‘dark matter’ that may help explain disease risk and healthy ageing.
Category: Health & Science
Ozempic and Wegovy Linked to Surprising Reduction in Violent Behaviour
A Rutgers University study found that GLP-1 receptor agonist drugs like Ozempic and Wegovy may reduce the link between impulsive tendencies and violent acts.
Scientists Unlock Mammalian Regeneration Using Two-Stage Gene Treatment
Researchers using a two-stage treatment redirected biology to demonstrate that the ability to regenerate complex body parts may be switched off rather than lost in mammals.
Common Plastic Chemical DEHP Linked to Lifelong Anxiety in Male Rats
Early-life exposure to DEHP, a plasticiser in medical devices and toys, caused lasting anxiety-like behaviour in male rats according to new research.
Daily Probiotics Alongside Antidepressants Improve Depression in Older Adults
A small clinical trial found that seniors taking probiotics with their antidepressants experienced slightly greater improvement in depressive symptoms.
Minimally Invasive Knee Procedure Delivers Year-Long Arthritis Pain Relief Without Surgery
A procedure blocking inflammation-driving blood vessels in the knee provided lasting pain relief for osteoarthritis patients with benefits enduring over a year.
Africa CDC Warns Ebola Outbreak in DRC Could Become Worst in History
The Africa CDC issued a warning that the DRC Ebola outbreak with 837 confirmed cases and nearly 200 deaths could surpass all previous outbreaks if underfunded.
FDA Approves Third Over-the-Counter Naloxone Nasal Spray to Fight Opioid Deaths
The FDA approved another OTC version of naloxone under the name Rextovy, widening access to the life-saving opioid overdose reversal treatment.
US Infant Mortality Falls to All-Time Low of 5.4 Deaths Per 1000 Births in 2025
CDC preliminary data shows US infant mortality reached a new record low in 2025, representing hundreds fewer deaths compared to previous years.
FDA Reviews Moderna mRNA Flu Vaccine Ahead of Advisory Committee Meeting
FDA reviewers found no serious safety or efficacy concerns with Moderna’s mRNA influenza vaccine for adults 50 and over ahead of a key advisory panel meeting.